Skip to content
10-Q

Quarterly Report

SELLAS Life Sciences Group, Inc. SLS

0001390478-25-000020

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 142.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 108.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 98.31M sh
Shares Diluted Q3 2025 · Sep 30, 2024 68.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.94M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$23.47M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$28.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $44.32M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $13.89M
Stockholders Equity Q3 2025 · Sep 30, 2025 $45.63M
Stockholders Equity Q3 2025 · Jun 30, 2025 $26.15M
Stockholders Equity Q3 2025 · Dec 31, 2024 $9.47M
Stockholders Equity Q3 2025 · Sep 30, 2024 $15.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.91M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$7.98M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.93M
Current Liabilities Q3 2025 · Dec 31, 2024 $9.51M
Total Liabilities Q3 2025 · Sep 30, 2025 $5.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $9.97M
Current Assets Q3 2025 · Sep 30, 2025 $49.05M
Current Assets Q3 2025 · Dec 31, 2024 $16.33M
Total Assets Q3 2025 · Sep 30, 2025 $51.56M
Total Assets Q3 2025 · Dec 31, 2024 $19.43M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.06
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.20
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.42
Eps Basic Q3 2025 · Sep 30, 2025 −$0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.20
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.42
Sga Expense Q3 2025 · Sep 30, 2025 $2.87M
Sga Expense Q3 2025 · Sep 30, 2025 $8.73M
Sga Expense Q3 2025 · Sep 30, 2024 $2.97M
Sga Expense Q3 2025 · Sep 30, 2024 $9.94M
Net Income Q3 2025 · Sep 30, 2025 −$6.79M
Net Income Q3 2025 · Sep 30, 2025 −$19.21M
Net Income Q3 2025 · Sep 30, 2024 −$7.11M
Net Income Q3 2025 · Sep 30, 2024 −$24.14M
Operating Income Q3 2025 · Sep 30, 2025 −$7.08M
Operating Income Q3 2025 · Sep 30, 2025 −$20.02M
Operating Income Q3 2025 · Sep 30, 2024 −$7.33M
Operating Income Q3 2025 · Sep 30, 2024 −$24.6M